Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CET

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
12/06 Moberg Pharma considers an acquisition of a brand from Prestige Brands and ev..
12/06 RITE AID : Siniawa plans retail center in W-B
12/06 RITE AID : Developer looking to attract tenants for proposed W-B center
12/05 RITE AID : Supports National Influenza Vaccination Week with Discounted Flu Shot..
12/05 RITE AID : Police investigate 'suspicious' death
12/01 MARCUS & MILLICHAP : Rite Aid in Midlothian sells for $3.4 million
12/01 RITE AID : McQueary unable to get a job at Rite Aid, and other key points by the..
11/29 RITE AID : Police arrest man after failed "bomb" robbery
11/25 RITE AID : Hackensack Meridian opening Rite Aid clinics
11/22 RITE AID : Customers Can Now Use American Express® Membership Rewards® Points fo..
More news
Sector news : Retail - Drugs without Grocery
11/16DJTarget Draws Back Shoppers
11/16DJWALGREENS BOOTS ALLIANCE : Claims Theranos Voided 11.3% of Test Reports
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
11/09DJWALGREENS BOOTS ALLIANCE : Walgreen Sues Theranos, Seeking to Recover $140 Milli..
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
12/07 Rite Aid seen as interesting arb pick
12/07 What Is The Top Arb Bet For 2017?
11/29 No Stopping The Rally? Cramer's Mad Money (11/28/16)
11/25 Black Friday (Arb) Bargains
11/22 The Superior Investment For Next Decade - Walgreens Boots Alliance Or CVS?
Advertisement
Financials ($)
Sales 2017 32 800 M
EBIT 2017 676 M
Net income 2017 126 M
Debt 2017 6 848 M
Yield 2017 -
P/E ratio 2017 63,92
P/E ratio 2018 43,21
EV / Sales 2017 0,47x
EV / Sales 2018 0,44x
Capitalization 8 501 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 8,58 $
Spread / Average Target 6,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION3.57%8 501
RAIA DROGASIL SA76.34%6 142
AIN HOLDINGS INC39.02%2 243
ORIOLA KD OYJ1.16%848
AUSTRALIAN PHARMACEUTI..-3.11%682
ADCOCK INGRAM HOLDINGS..-5.57%596
More Results